logo
Company outlines how reduction of paramedics in air ambulance service poses safety risks

Company outlines how reduction of paramedics in air ambulance service poses safety risks

Irish Examiner22-05-2025

The company which provides a life-saving air ambulance service for the State raised serious concerns about flight safety risks after the HSE's National Ambulance Service (NAS) introduced changes to the medical crewing model on the aircraft.
The crew changes included rostering just one paramedic to work some of the shifts on the aircraft, which operates from a base near Millstreet, in Cork, to covering the south west and beyond.
In an explosive email, a senior official in Gulf Med Aviation Services (GMAS), which provides the aircraft and pilots for the service under contract to the NAS, said since the changes:
he had seen a marked deterioration in how the medical staff on board the helicopter perform their aviation tasks while tasked to work shifts on the helicopter;
he had seen "workflow and cognitive errors" in the aviation-focused tasks the medical crew need to perform safely as part of the helicopter crew;
and how the 'low levels of motivation, concentration, and attention to the task' that appear to have resulted from the recent medical crew changes is 'evident and impactful'.
Malta-based GMAS went so far as to formally ask NAS officials for 'an intervention at the earliest opportunity' to address the issues, which were flagged in February.
The HSE has insisted, however, that the helicopter emergency medical service (HEMS) is safe and working effectively, that the crewing model is safe for both patients and crew, and that there are no outstanding matters of concern in relation to the contract.
The revelation comes just weeks after the Irish Examiner reported how the HEMS covering the south was at risk of being grounded in a row over NAS moves to cut the number of paramedics rostered to work on the aircraft from two to just one. Farm safety minister Michael Healy-Rae described any such move as 'reckless'.
The crewing changes were being advanced despite internal reports warning HSE and NAS management that a solo paramedic crewing model poses a risk to patients, to the paramedics and pilots, and poses a flight safety risk.
The Irish Examiner reported last March how one internal report warned that if the NAS couldn't provide two paramedics for each of the HEMS aircraft, then the service should be stood down on those days. The HEMS is currently operating several shifts with just one medical crew member on board.
The National Ambulance Service provides two dedicated HEMS responses in Ireland - one based in Cork, operated by GMAS, and the other in Athlone operated by the Air Corps - with medical staff on both aircraft supplied by the NAS. File picture: Dan Linehan
A senior manager also warned that a single patient safety incident such as a drug error, an in-flight patient emergency, or in the worst-case scenario, a crash, would bring the crewing issue 'sharply into focus'.
Concerns were also expressed in March that the NAS was recruiting emergency medical technicians (EMTs) to replace the second paramedic on the aircraft.
Qualifying as an EMT takes just five weeks. EMTs cannot perform any of the major 'interventional skills' required to help critically ill patients, including intubation – the placing of a tube in a patient's airway – and the intravenous administration of powerful painkillers, which are often required of patients who need an air ambulance.
The NAS provides two dedicated HEMS responses in Ireland - one based in Cork, operated by GMAS, and the other in Athlone operated by the Air Corps - with medical staff on both aircraft supplied by the NAS.
In 2022, GMAS won the competitive tender for the delivery of the Cork-based service, taking over from the previous charity provider in February 2023. It is understood the company won the tender again earlier this year.
GMAS has an aviation safety management system (SMS) which underwrites the approval of its HEMS service here by its regulator, TM-CAD, the civil aviation directorate in Malta.
The National Ambulance Service said it takes concerns raised around the safety of its services very seriously. File picture: Larry Cummins
But earlier this year, concerns were emerging from within the service about changes the NAS was making to the medical crewing model on board the aircraft, which included reducing the number of paramedics rostered to work the aircraft from two to just one on certain shifts.
In his letter to NAS officials in February, the GMAS official said the HEMS base in Cork had been operating for about two months with a limited medical team on the helicopter.
'It is important that as the operator of the service, we ensure our SMS processes are robust and commensurate with the acceptable risks that prevail during intensive HEMs operations,' he wrote.
'As we understand it, the advanced paramedics are generally spending seven shifts on the helicopter operation within a five-week period. The complex mix of other duties away from the HEMS operation further reduces their capacity to cope.
'As a result, Gulf Med is experiencing workflow and cognitive errors in the aviation centric tasks required of the paramedics that are critical for them to safely interface with the aviation side of the operation. In addition, the low levels of motivation, concentration, and attention to the task that appear to have resulted from the recent changes is evident and impactful.'
The company said safety is the number one consideration for all aviation operations and the regulations demand that due attention is given to the management of changes.
'In this case, the HEMs Rathcoole unit has seen three new HEMs paramedics very recently trained and allocated to the helicopter,' the GMAS official said.
'These individuals were trained and certified in a multi-practitioner role (two medical crew on board) and had barely consolidated before being rostered in the single practitioner role on the helicopter. The risks involved in such a change are self-evident.
'For example, a paramedic returning from a significant period away from the unit is often required to mount a HEMS mission in the first few minutes of arriving at the base. This is not a safe practice.'
It said like most safety critical activities, all that has to happen for a serious incident or an accident to occur, is for the good people involved to do nothing.
The Gulf Med official said he felt they were at the point where something needs to be done to improve:
the recent experience of all staff on board the helicopter to match the risks involved in the operation;
the mental capacity of junior members of the team to cope with the HEMs role;
and a reduction in the disruption and changes that are clearly affecting the motivation, concentration and attention to detail that is necessary to remain safe.
GMAS did not respond to requests to comment.
Any issues relating to a contract like this, and which are being raised for resolution, must be raised by the relevant company through a formal contract management framework which has been established through the relevant public procurement process.
In a response to queries from the Irish Examiner, the NAS said it takes concerns raised around the safety of its services very seriously.
'Any concerns or issues raised in relation to the HEMS are escalated through our agreed contract management process and dealt with expeditiously,' it said in a statement. 'Currently the HSE and Gulf Med Aviation Services are satisfied that services are safe and working effectively.
'The crewing model for the HSE's HEMS is safe for patients and staff. Since its inception in June 2012, the HSE HEMS has operated a successful crewing model consisting of one specialist paramedic and one EMT.
'In September 2024, the HSE commenced a feasibility study to examine the need for physician-delivered HEMS in Ireland. The preliminary results of the trial have not supported any change to the HEMS crewing model, hence the trial period has been extended into 2025.'
The HSE said both of its HEMS continue to operate normally, with further support, if required, provided through the Irish Coast Guard's search and rescue aviation service.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Serious alarm' over non-medical sales of weight-loss jabs
‘Serious alarm' over non-medical sales of weight-loss jabs

Extra.ie​

time31 minutes ago

  • Extra.ie​

‘Serious alarm' over non-medical sales of weight-loss jabs

A warning from the medicines watchdog that weight-loss drugs such as Ozempic are increasingly becoming available through non-medical routes is a cause of 'serious alarm', Independent TD Carol Nolan has said. The Health Products Regulatory Authority (HPRA) issued an 'urgent warning' in recent days about false claims being made online for sales of counterfeit semaglutide, using the HPRA logo. Last December, RTÉ Investigates examined the sale of unapproved US weight-loss medication in Ireland which revealed the extent of the booming black market in the prescription weight-loss drugs. Medical experts were especially worried about serious health risks from the use of weight-loss pens from Turkey, counterfeit semaglutide pens used as an anti-obesity medication, and unlabelled glass vials openly advertised on social media. A warning from the medicines watchdog that weight-loss drugs such as Ozempic are increasingly becoming available through non-medical routes is a cause of 'serious alarm', Independent TD Carol Nolan has said. Pic: Getty Images Ms Nolan said the most alarming feature of the official response was 'increasing concern around off-licence use and access through unofficial sources, which is not supported and poses significant safety risks'. In queries to the HSE, Ms Nolan said: 'I have been contacted by a number of people who have expressed unease regarding the potential adverse health side-effects and long-term harms that may be induced when a person uses Ozempic medication for weight loss.' In a letter to the embattled organisation, Ms Nolan also asked: 'Has the HSE conducted any research on this matter and is the HSE aware of the apparently growing international literature highlighting adverse outcomes for those who use Ozempic?' One source said: 'It is quite common and easily secured. Often it's a mother-daughter bonding before weddings and holidays' Responding, HSE manager Ann Horgan said: 'I have consulted with the National Clinical Programme (NCP) for Obesity on your question and have been informed the NCP is actively monitoring emerging international evidence on the efficacy and safety of GLP-1 receptor agonists, such as semaglutide. 'The HSE was represented at the European Congress of Obesity in Malaga in May 2025, where the use of obesity medications was discussed. When used as licensed and under clinical supervision, the benefits of semaglutide are considered to outweigh the risks for appropriately selected patients.' The HPRA said last week it had seen a 'surge' in misleading website activity in May alone. It said: 'The websites, which are hosted outside of Ireland by the e-commerce platform Shopify, are being directly prompted to consumers via fake Facebook profiles and ads.' Pic: Getty Images Commenting on the concerns, Ms Nolan said: 'I would urge everyone who is considering going down the Ozempic route to limit their engagement to medical professionals prior to embarking on a course of medication. 'I understand there may be a sense of urgency among some people and a sense that they do not have time to wait in terms of accessing a massively over-burdened primary care and hospital service. But the dangers are real and cannot be ignored. 'I would also highlight our need to dramatically ramp up our detection capacity in terms of taking any illegal consignments of Ozempic out of the public space. 'We are all aware of recent media investigations on this issue and still the problem appears to be escalating. 'That is deeply alarming given the potential for such dire health outcomes for people who may be drawn in by ruthless individuals who couldn't give a damn about what impact unregulated medication access causes

Fund set up by Micheál Martin 20 years ago to cut hospital waiting lists under fresh scrutiny
Fund set up by Micheál Martin 20 years ago to cut hospital waiting lists under fresh scrutiny

Irish Times

time3 hours ago

  • Irish Times

Fund set up by Micheál Martin 20 years ago to cut hospital waiting lists under fresh scrutiny

In February, Jennifer Carroll MacNeill became the latest Minister for Health to announce a new initiative to reduce the amount of time patients have to wait for treatment in public hospitals . The Irish health system has been struggling for years to deal with growing waiting lists with bed and staffing capacity lagging behind demand. The answer for successive governments has been to either use the private sector or to get existing personnel to do more in their own time, while the Health Service Executive moved to increase its own resources. The amount of money allocated to these initiatives has been staggering. The Minister's plan in February involved a €420 million investment, including €190 million for the HSE and €230 million for the National Treatment Purchase Fund (NTPF) – the organisation established by Micheál Martin 20 years ago to buy treatment for public patients. READ MORE Between 2022 and 2024 under Stephen Donnelly , about €1.23 billion was allocated to the HSE and the NTPF. Government funding was essentially spent in three ways. First, it allowed the HSE to appoint more staff to increase its own capacity. Second, it allowed the NTPF to buy care in private facilities. Third, it allowed for what is known as 'insourcing', where health service personnel are paid by the NTPF or other entities to provide treatment outside normal hours in public hospitals for those on waiting lists. A recent internal report carried out by children's healthcare group CHI , has led to more intense scrutiny of the various waiting list initiatives. The report alleged that a doctor had delayed operations on children before eventually they were treated at weekend clinics that he was operating separately. In the Dáil, the Taoiseach said the CHI report 'makes for shocking reading of the most profound kind, which not just goes to the heart of the misuse of NTPF funding but more seriously raises fundamental concerns at that time about safety for children receiving surgery'. Cian O'Callaghan of the Social Democrats told the Dáil that the report found the consultant earned more than €35,000 by keeping very young children on a waiting list for years. 'They were eventually treated using the NTPF when they were transferred to the consultant's weekend clinic, but they could have been treated by other doctors years earlier. When all of this was discovered, it was kept a secret and the consultant was allowed to retire and sail into the sunset.' The Minister and HSE chief Bernard Gloster had been kept in the dark about the report but were given copies last week. There have been other controversies surrounding waiting list funding. On April 18th, Mr Gloster directed his senior leadership team to halt, for the present at least, aspects of the 'insourcing' arrangements. He commissioned a survey to establish the dependency of the health system on such practices and to ensure 'there were no unintended consequences'. Mr Gloster suspended insourcing where staff were 'engaged, hired or paid' by separate entities on initiatives in their area of work. Insourcing was only permitted in cases where the HSE directly engaged its own staff through payroll. His instructions followed discussions with Ms Carroll MacNeill and followed an internal audit report, details of which were revealed in The Irish Times last September. The HSE internal audit found two companies which received more than €1.5 million between them in contracts awarded by University Hospital Limerick without a competitive procurement process were owned or part-owned by employees at the facility. A third company, which received a contract of nearly €400,000, had a HSE employee at a different hospital as a director. Auditors stated €14.2 million was paid out to third-party providers by University Hospital Limerick in 2023 under the Government waiting list initiative without an open procurement process. Auditors said there was no evidence of the HSE employees being involved in the awarding of the contracts. In May, Aontú leader Peadar Tóibín told the Dáil in one case a consultant created a firm to read scans and 'used the hospital public waiting lists to then funnel work through rostering into his own private company'. The NTPF said it was deeply concerned at the CHI internal report. It said it had never received any complaints about hospitals or doctors. Last year, the fund paid €155 million to private hospitals and about €80 million to public facilities. It seeks private hospitals to tender for packages of care and it then attempts to match this capacity with those waiting longest in public facilities. Sara Burke, associate professor of health policy at Trinity College, said the NTPF and the various waiting list initiatives were initially established more than 20 years ago as temporary measures while the State built up its own public capacity. They had, however, become permanent, integral parts of the system, she said. 'Given the amounts of money now being allocated, there is a need to look at how transparent the arrangements are and the governance of these schemes,' she said. The Opposition is now calling for reforms. David Cullinane of Sinn Féin said there were concerns about potential conflicts of interest and called for a centralised system which would see patients referred to a hospital rather than an individual consultant. 'We have to ask genuine questions about what work some consultants are doing from Monday to Friday to carry out public procedures. We need to contrast that with the so-called blitzes and private clinics they are organising and running, while charging €200 for each client they see and making very handsome amounts of money.' Marie Sherlock of the Labour Party said she was uncomfortable about how the current arrangements had grown, the dependency on it that had developed and 'the ability of the public system to wean itself off it'. Mr Tóibín questioned the safeguards in place against conflicts of interest. 'Last year 80,000 public patients were treated in private hospitals at a cost of €100 million. The majority of these treatments should have been done in the public system.' Ms Carroll MacNeill told the Dáil she would be taking further steps to remove the anomalies, which she said existed 'because of the overhanging mix of public and private activity'.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store